Enhanced stimulation of erythropoiesis
CA 2263978 A1 · Owner: Hemosol Inc. · Inventors: Mueller, Susan; Bell, David
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed to compositions comprising heme-containing components and to methods that stimulate erythropoiesis comprising administration of a composition of the invention such as purified hemoglobin. , Surprisingly heme-containing components such as hemoglobin can induce erythopoiesis in the presence of decreased concentrations of erythropoietin (Epo) and, in fact, function synergistically with Epo. Further heme-, containing components can be used alone or in conjunction with Epo for the treatment of anemias and other disorders due to decreases in erythropoietin or iron. It has been discovered that, in the presence of Epo both hemoglobin and , cross-linked …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 27, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 27, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 27, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.